Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 77,947 $ 64,615
Accounts receivable 3,015 5,006
Accounts receivable due from related parties 1,316 1,316
Prepaid expenses and other current assets 1,182 11,298
Total current assets 83,460 82,235
Property, plant and equipment, net 62,932 153,040
Deferred engineering costs 110,499 106,425
Non-current restricted cash 3,441 3,867
Other non-current assets 32,980 36,755
Total assets 293,312 382,322
Current liabilities:    
Accounts payable 24,617 21,048
Accounts payable due to related parties (Note 7) 1,360 0
Accrued and other liabilities 35,450 33,003
Borrowings 80,774 78,528
Total current liabilities 142,201 132,579
Borrowings 37,659 58,121
Other non-current liabilities 26,811 25,337
Total long-term liabilities 64,470 83,458
Stockholders’ equity:    
Preferred stock, $0.01 par value, 100,000,000 authorized: 6,123,782 and 6,123,782 shares outstanding, respectively 61 61
Common stock, $0.01 par value, 800,000,000 and 400,000,000 authorized, respectively: 326,131,890 and 242,207,522 shares outstanding, respectively 3,036 2,211
Additional paid-in capital 888,216 769,639
Accumulated deficit (804,672) (605,626)
Total stockholders’ equity 86,641 166,285
Total liabilities and stockholders’ equity $ 293,312 $ 382,322